Pathways’ Picks December 16: Rulemaking Spotlight, Global View, and More to Watch

article image

In this week’s roundup: The medtech-championed Medicare Coverage of Innovative Technologies program is on track for near-term finalization; WHO issues device postmarket guidance; FDA rolls out home-based COVID-19 EUAs, and more.

CMS has made quick work toward realizing its proposal to nationally cover Breakthrough Devices automatically upon FDA approval for four years. A final version of the agency’s Medicare Coverage of Innovative Technologies (MCIT) rule was sent to the White House Office of Information and Regulatory Affairs December 14, according to OIRA’s online dashboard, meaning CMS and HHS overseers have completed work on it, just three-and-a-half months after the proposed rule was released and one-and-a half months after public comments were due. That and much more in the latest Pathways’ Picks.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: